These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24251901)

  • 1. The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats.
    Goutier W; Kloeze MB; McCreary AC
    Addict Biol; 2015 Mar; 20(2):248-58. PubMed ID: 24251901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice.
    Biala G; Staniak N
    Pharmacol Biochem Behav; 2010 Aug; 96(2):141-7. PubMed ID: 20451547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of brain and behavioral effects of varenicline and nicotine in rats.
    King J; Huang W; Chen W; Heffernan M; Shields J; Rane P; Bircher R; DiFranza JR
    Behav Brain Res; 2011 Sep; 223(1):42-7. PubMed ID: 21527291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of varenicline on the acute and repeated locomotor responses to nicotine in rats.
    Zaniewska M; McCreary AC; Stefański R; Przegaliński E; Filip M
    Synapse; 2008 Dec; 62(12):935-9. PubMed ID: 18798299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of nicotine induced behavioral sensitization on dopamine D1 receptor pharmacology: An in vivo and ex vivo study in the rat.
    Goutier W; O'Connor JJ; Lowry JP; McCreary AC
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):933-43. PubMed ID: 25795518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.
    Turner JR; Wilkinson DS; Poole RL; Gould TJ; Carlson GC; Blendy JA
    Neuropsychopharmacology; 2013 Sep; 38(10):2035-47. PubMed ID: 23624742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.
    Spiller K; Xi ZX; Li X; Ashby CR; Callahan PM; Tehim A; Gardner EL
    Neuropharmacology; 2009 Jul; 57(1):60-6. PubMed ID: 19393252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varenicline disrupts prepulse inhibition only in high-inhibitory rats.
    Goktalay T; Buyukuysal S; Uslu G; Coskun AS; Yorgancioglu A; Kayir H; Uzbay T; Goktalay G
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():54-60. PubMed ID: 24632394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking.
    Steensland P; Simms JA; Holgate J; Richards JK; Bartlett SE
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12518-23. PubMed ID: 17626178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
    Coe JW; Brooks PR; Vetelino MG; Wirtz MC; Arnold EP; Huang J; Sands SB; Davis TI; Lebel LA; Fox CB; Shrikhande A; Heym JH; Schaeffer E; Rollema H; Lu Y; Mansbach RS; Chambers LK; Rovetti CC; Schulz DW; Tingley FD; O'Neill BT
    J Med Chem; 2005 May; 48(10):3474-7. PubMed ID: 15887955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
    Loughead J; Ray R; Wileyto EP; Ruparel K; Sanborn P; Siegel S; Gur RC; Lerman C
    Biol Psychiatry; 2010 Apr; 67(8):715-21. PubMed ID: 20207347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats.
    O'Connor EC; Parker D; Rollema H; Mead AN
    Psychopharmacology (Berl); 2010 Feb; 208(3):365-76. PubMed ID: 19967529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system.
    Ericson M; Löf E; Stomberg R; Söderpalm B
    J Pharmacol Exp Ther; 2009 Apr; 329(1):225-30. PubMed ID: 19126781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia.
    Wecker L; Engberg ME; Philpot RM; Lambert CS; Kang CW; Antilla JC; Bickford PC; Hudson CE; Zesiewicz TA; Rowell PP
    Neuropharmacology; 2013 Oct; 73():75-86. PubMed ID: 23711550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine-induced locomotor sensitization: pharmacological analyses with candidate smoking cessation aids.
    Goutier W; Kloeze M; McCreary AC
    Addict Biol; 2016 Mar; 21(2):234-41. PubMed ID: 25307867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varenicline improves mood and cognition during smoking abstinence.
    Patterson F; Jepson C; Strasser AA; Loughead J; Perkins KA; Gur RC; Frey JM; Siegel S; Lerman C
    Biol Psychiatry; 2009 Jan; 65(2):144-9. PubMed ID: 18842256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.
    Mihalak KB; Carroll FI; Luetje CW
    Mol Pharmacol; 2006 Sep; 70(3):801-5. PubMed ID: 16766716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats.
    LeSage MG; Shelley D; Ross JT; Carroll FI; Corrigall WA
    Pharmacol Biochem Behav; 2009 Jan; 91(3):461-7. PubMed ID: 18817808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats.
    Paterson NE; Min W; Hackett A; Lowe D; Hanania T; Caldarone B; Ghavami A
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1455-64. PubMed ID: 20708056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.